Litcius/Paper detail

End resistance to dolutegravir roll-out

The Lancet HIV

2020The Lancet HIV34 citationsDOIOpen Access PDF

Topics & Concepts

DolutegravirMedicineEfavirenzTolerabilityEmtricitabineVirologyLamivudineIntegrase inhibitorHuman immunodeficiency virus (HIV)Antiretroviral therapyPharmacologyAdverse effectViral loadVirusHepatitis B virusHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsPneumocystis jirovecii pneumonia detection and treatment